Low doses of silver make bacteria more susceptible to antibiotic attack, paving the way for new therapies for drug-resistant and recurrent infections
Slipping bacteria some silver could give old antibiotics new life, scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University reported June 19 in Science Translational Medicine.
Treating bacteria with a silver-containing compound boosted the efficacy of a broad range of widely used antibiotics and helped them stop otherwise lethal infections in mice. It helped make an antibiotic-resistant strain of bacteria sensitive to antibiotics again. And it expanded the power of an antibiotic called vancomycin that is usually only effective in killing pathogens called Gram-positive bacteria, such as Staph and Strep. Silver allowed vancomycin for the first time to penetrate and kill Gram-negative bacteria, a group that includes microbes that can cause food poisoning and dangerous hospital-acquired infections.
Silver also proved useful for two types of stubborn infections that usually require repeated rounds of antibiotic treatment and multiple visits to the clinic: dormant bacteria that lie low during antibiotic treatment and rebound to cause recurrent infections, and microbial slime layers called biofilms that coat catheters and prosthetic joints.
“The results suggest that silver could be incredibly valuable as an adjunct to existing antibiotic treatments,” said Jim Collins, Ph.D., a pioneer of synthetic biology and Core Faculty member at the Wyss Institute, who is also the William F. Warren Distinguished Professor at Boston University, where he leads the Center of Synthetic Biology.
In recent years more disease-causing bacteria have grown resistant to common antibiotics, with serious public health consequences. Yet drug companies have struggled for years to develop new types of antibiotics that target these tough bacteria. That has led scientists to re-examine older methods that were used to fight infection well before penicillin use took off in the 1940s. Silver treatment, which has been used since antiquity to prevent and heal infections, is one of them.
Despite silver’s long history of use in the clinic, no one understood fully how it killed bacteria.To find out, Ruben Morones-Ramirez, Ph.D., a postdoctoral fellow at the Wyss Institute who left recently to become a professor at Universidad Autònoma de Nuevo Leon in Mexico, treated normal and mutant strains of E. coli bacteria with a silver compound. Then he observed them under the electron microscope and ran a series of biochemical tests.
He found that silver compounds cause bacteria to produce more reactive oxygen species – chemically reactive molecules that damage the bacterial cell’s DNA and enzymes, as well as the membrane that encloses the cell. Silver also made the bacteria’s cell membrane leakier.
Although silver was used alone as a therapy in the past, the scientists suspected that both changes might make cells more vulnerable to conventional antibiotics — and they did. A small amount of silver made E. coli bacteria between 10 and 1000 times more sensitive to three commonly used antibiotics: gentamycin, ofloxacin, and ampicillin.
“If you know the mechanism, you can have much more success making combinatorial therapies,” Morones-Ramirez said.
In mice, silver also helped antibiotics fight E. coli-induced urinary-tract infections. It made a previously impervious strain of E. coli sensitive to the antibiotic tetracycline. And it allowed vancomycin to save the lives of 90 percent of mice with life-threatening cases of peritonitis — inflammation caused by infections of the abdominal space surrounding the internal organs. Without silver, only 10 percent of the mice survived.
The scientists also did a series of toxicity studies, showing that the doses of silver needed to help antibiotics kill bacteria were far below what could harm the mice. Nor did they harm cultured human cells, suggesting that oral and injectable silver could be safe for humans as well.
The Latest Bing News on:
Drug-resistant and recurrent infections
- Common antibiotic Neosporin may shield against viral respiratory infectionson April 26, 2024 at 9:00 am
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
- Antibiotic-resistant hospital infections well above pre-COVID-19 levelson April 26, 2024 at 8:02 am
Hospital-acquired antimicrobial-resistant infections remain at least 12% above pre-pandemic levels, according to a new study from data at 120 U.S. hospitals. Researchers analyzed trends in the ...
- What to Know About Pivya, the New Antibiotic Treatment for UTIson April 26, 2024 at 4:06 am
The Food and Drug Administration recently approved Pivya (pivmecillinam) to treat uncomplicated UTIs in female adults. Clinical trials show that Pivya is effective and side effects are limited.
- F.D.A. Approves Antibiotic for Increasingly Hard-to-Treat Urinary Tract Infectionson April 24, 2024 at 1:45 pm
Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.
- Antibiotic Resistance Rates in Causative Agents of Infections in Diabetic Patientson April 23, 2024 at 5:00 pm
Due to common or recurrent infections, diabetic patients have more antibiotic treatments compared with other subjects, which can increase the antibiotic resistance rates in the bacteria.
- A new UTI vaccine shows promise in preventing recurrent infectionson April 10, 2024 at 1:59 pm
The issue traditionally is treated with antibiotics, but that has become more challenging due to rising antibiotic resistance. This oral spray may offer another option.
- Drug-Resistant Infections: A Threat to Our Economic Futureon April 4, 2024 at 8:49 pm
Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...
- Global alarm as drug-resistant fungal infections rise, deaths near 2 millionon March 20, 2024 at 10:29 am
Around the world, an increasing number of infections are caused by drug-resistant fungi. According to the latest research, published in the prestigious scientific journal "Pathogens and Immunity ...
- Researchers report rise in global fungal drug-resistant infectionson March 18, 2024 at 12:00 pm
A global wave of infections caused by fungi growing drug-resistant has the medical community issuing precautions on how to protect yourself. Skin contact with microorganisms found in soil or on ...
- Puppies, What Did You Do Now? Antibiotic Resistant Infections In 118 Peopleon September 20, 2018 at 9:04 pm
Getting an antibiotic-resistant Campylobacter jejuni infection can be ... pregnant, or with a chronic disease can be at higher risk for complications from a Campylobacter infection.
The Latest Google Headlines on:
Drug-resistant and recurrent infections
[google_news title=”” keyword=”drug-resistant and recurrent infections” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
New antibiotics
- Study: Antibiotic use in moderate COVID-19 linked to clinical deteriorationon April 26, 2024 at 7:56 am
Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona,
- New antibiotics aren’t being fully used, study findson April 23, 2024 at 2:02 pm
A new study shows that, despite having newer options for antibiotic-resistant infections, US clinicians are still frequently opting for less optimal older, generic antibiotics.
The Latest Google Headlines on:
New antibiotics
[google_news title=”” keyword=”new antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]